Vice President Quality Assurance
Blackrock Neurotech
Vice President Quality Assurance
Blackrock Neurotech
Develops implantable neural interfaces for communication
At Blackrock Neurotech, we’ve spent decades making the impossible possible – helping people move, speak, and reconnect with the world when they otherwise could not. We’ve seen that restoring function restores more than ability. It restores independence, identity, and agency.
Today, we are building the next generation of human capability: brain-computer interfaces that are designed to be safe, scalable, and trusted in the real world. Our work is not only about reconnecting people to what was lost, but about expanding what is possible – creating a seamless interface between human intent and technology.
This is foundational work in a category-defining field. You will help build the infrastructure for a future where neural interfaces are invisible, reliable, and deeply human-centered.
The Vice President Quality Assurance, Regulatory and Clinical Affairs will lead Blackrock Neurotech’s Clinical Affairs, Regulatory Affairs, and Quality Assurance functions, with full strategic and operational ownership of all three. You will set the clinical, regulatory, and quality strategy that supports the development, clinical advancement, regulatory approval, and commercialization of next-generation neurotechnology and implantable brain-computer interface products.
You will build one integrated strategy that connects clinical evidence generation, regulatory pathways, and quality systems to the company’s product development and business objectives. You will own the clinical program end to end, including study design, execution, data integrity, and alignment of study milestones with regulatory submissions and product goals. You will lead regulatory strategy and engagement with FDA and global authorities through approval and post-market obligations. You will maintain a robust, scalable Quality Management System and ensure compliance with all applicable global requirements. Leaders across Clinical Affairs, Regulatory Affairs, and Quality Assurance will report to you, and you will be accountable for the performance, development, and growth of these teams.
As a member of the leadership team, you will report directly to the CEO and partner with leaders across R&D, Engineering and Operations to assess current capabilities, set clear priorities, and build the people, processes, and systems needed to advance clinical milestones and support long-term commercialization.
You will operate with meaningful ownership in a high-consequence environment, contributing to systems that must be precise, reliable, and durable.
We are a small, experienced team working on consequential problems.
This is a high-ownership role, but it is not an "always-on" one. We expect strong work and our people to have a life outside of it.
Working Location:
Making Salt Lake City, UT your home base is ideal, however, we will consider remote work for this position. We ask that remote employees commit to regular on-site visits for routine work and departmental events.
[]
Develops implantable neural interfaces for communication
Blackrock Neurotech develops brain-computer interface (BCI) technology. Its main offering is the Utah Array, a microelectrode device implanted in the brain to record neural signals, along with software and hardware to decode those signals so users can control computers, prosthetic limbs, or other devices. The company sells its BCI systems to research institutions and medical device companies and also provides engineering and consulting services to support implementation. Unlike many competitors that focus on noninvasive or software-only solutions, Blackrock Neurotech provides invasive neural interfaces with a complete hardware–software pipeline for recording, decoding, and using brain activity. Its goal is to help people with paralysis and other neurological disorders communicate and interact with their surroundings by restoring neural communication through implanted interfaces.
Explore more opportunities at Blackrock Neurotech